160 related articles for article (PubMed ID: 8239983)
21. Cellular mechanisms in ischemic preconditioning: the role of adenosine and protein kinase C.
Downey JM; Cohen MV; Ytrehus K; Liu Y
Ann N Y Acad Sci; 1994 Jun; 723():82-98. PubMed ID: 8030927
[No Abstract] [Full Text] [Related]
22. Activation of RISK and SAFE pathways is not involved in the effects of Cx43 deficiency on tolerance to ischemia-reperfusion injury and preconditioning protection.
Sánchez JA; Rodríguez-Sinovas A; Barba I; Miró-Casas E; Fernández-Sanz C; Ruiz-Meana M; Alburquerque-Béjar JJ; García-Dorado D
Basic Res Cardiol; 2013 May; 108(3):351. PubMed ID: 23595215
[TBL] [Abstract][Full Text] [Related]
23. Preconditioning: can nature's shield be raised against surgical ischemic-reperfusion injury?
Perrault LP; Menasché P
Ann Thorac Surg; 1999 Nov; 68(5):1988-94. PubMed ID: 10585117
[TBL] [Abstract][Full Text] [Related]
24. Activity of the Na+/H+ exchanger contributes to cardiac damage following ischaemia and reperfusion.
Allen DG; Xiao XH
Clin Exp Pharmacol Physiol; 2000 Sep; 27(9):727-33. PubMed ID: 10972541
[TBL] [Abstract][Full Text] [Related]
25. Different preconditioning stimuli invoke disparate electromechanical and energetic responses to global ischemia in rat hearts.
Rehring TF; Bender PR; Cairns CB; Joo K; Friese RS; Shapiro JI; Cleveland JC; Banerjee A
Can J Physiol Pharmacol; 1997 Apr; 75(4):335-42. PubMed ID: 9196860
[TBL] [Abstract][Full Text] [Related]
26. Anti-stunning and anti-infarct effects of adenosine-enhanced ischemic preconditioning.
Toyoda Y; Di Gregorio V; Parker RA; Levitsky S; McCully JD
Circulation; 2000 Nov; 102(19 Suppl 3):III326-31. PubMed ID: 11082409
[TBL] [Abstract][Full Text] [Related]
27. Adenosine in myocardial protection in on-pump and off-pump cardiac surgery.
Vinten-Johansen J; Zhao ZQ; Corvera JS; Morris CD; Budde JM; Thourani VH; Guyton RA
Ann Thorac Surg; 2003 Feb; 75(2):S691-9. PubMed ID: 12607714
[TBL] [Abstract][Full Text] [Related]
28. Cardioprotection induced by hydrogen sulfide preconditioning involves activation of ERK and PI3K/Akt pathways.
Hu Y; Chen X; Pan TT; Neo KL; Lee SW; Khin ES; Moore PK; Bian JS
Pflugers Arch; 2008 Jan; 455(4):607-16. PubMed ID: 17674030
[TBL] [Abstract][Full Text] [Related]
29. A "second window of protection" or delayed preconditioning phenomenon: future horizons for myocardial protection?
Yellon DM; Baxter GF
J Mol Cell Cardiol; 1995 Apr; 27(4):1023-34. PubMed ID: 7563099
[No Abstract] [Full Text] [Related]
30. Late preconditioning against myocardial stunning. An endogenous protective mechanism that confers resistance to postischemic dysfunction 24 h after brief ischemia in conscious pigs.
Sun JZ; Tang XL; Knowlton AA; Park SW; Qiu Y; Bolli R
J Clin Invest; 1995 Jan; 95(1):388-403. PubMed ID: 7814639
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms of ischemic preconditioning in rat hearts. Involvement of alpha 1B-adrenoceptors, pertussis toxin-sensitive G proteins, and protein kinase C.
Hu K; Nattel S
Circulation; 1995 Oct; 92(8):2259-65. PubMed ID: 7554210
[TBL] [Abstract][Full Text] [Related]
32. Preconditioning and its potential role in myocardial protection during cardiac surgery.
Lasley RD; Mentzer RM
J Card Surg; 1995 Jul; 10(4 Pt 1):349-53. PubMed ID: 7549193
[TBL] [Abstract][Full Text] [Related]
33. [Postconditioning: a brief review].
Schipke JD; Kerendi F; Gams E; Vinten-Johansen J
Herz; 2006 Sep; 31(6):600-6. PubMed ID: 17036192
[TBL] [Abstract][Full Text] [Related]
34. Cardiac preconditioning does not require myocardial stunning.
Mitchell MB; Winter CB; Locke-Winter CR; Banerjee A; Harken AH
Ann Thorac Surg; 1993 Feb; 55(2):395-400. PubMed ID: 8431049
[TBL] [Abstract][Full Text] [Related]
35. Toward the heart of ischemic preconditioning.
Dekker LR
Cardiovasc Res; 1998 Jan; 37(1):14-20. PubMed ID: 9539853
[No Abstract] [Full Text] [Related]
36. Preconditioning by isoflurane retains its protection against ischemia-reperfusion injury in postinfarct remodeled rat hearts.
Lucchinetti E; Jamnicki M; Fischer G; Zaugg M
Anesth Analg; 2008 Jan; 106(1):17-23, table of contents. PubMed ID: 18165546
[TBL] [Abstract][Full Text] [Related]
37. Calcium preconditioning in human myocardium.
Cain BS; Meldrum DR; Meng X; Shames BD; Banerjee A; Harken AH
Ann Thorac Surg; 1998 Apr; 65(4):1065-70. PubMed ID: 9564929
[TBL] [Abstract][Full Text] [Related]
38. Pretreatment with an adenosine A1 receptor agonist and lidocaine: a possible alternative to myocardial ischemic preconditioning.
Canyon SJ; Dobson GP
J Thorac Cardiovasc Surg; 2005 Aug; 130(2):371-7. PubMed ID: 16077401
[TBL] [Abstract][Full Text] [Related]
39. The effect of body temperature on myocardial protection conferred by ischaemic preconditioning or the selective adenosine A1 receptor agonist GR79236, in an anaesthetized rabbit model of myocardial ischaemia and reperfusion.
Sheldrick A; Gray KM; Drew GM; Louttit JB
Br J Pharmacol; 1999 Sep; 128(2):385-95. PubMed ID: 10510449
[TBL] [Abstract][Full Text] [Related]
40. A comparison of adenosine-induced cardioprotection and ischemic preconditioning in dogs. Efficacy, time course, and role of KATP channels.
Yao Z; Gross GJ
Circulation; 1994 Mar; 89(3):1229-36. PubMed ID: 8124811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
